Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bachas

Showing results (141-150 of 433) with videos related to

Pageof 44
Sort By:
Oncogenesis|June 19, 2019
Targeting the cell cycle in head and neck cancer by Chk1 inhibition: a novel concept of bimodal cell deathAnne M van Harten, Marijke Buijze, Richard van der Mast, et al.
BMC Bioinformatics|August 22, 2018
Rscreenorm: normalization of CRISPR and siRNA screen data for more reproducible hit selectionCosta Bachas, Jasmina Hodzic, Johannes C van der Mijn, et al.
Ecotoxicology and Environmental Safety|May 7, 2024
Characterization of fire investigators' polyaromatic hydrocarbon exposures using silicone wristbandsUmer Bakali, Jeramy L R Baum, Paola Louzado-Feliciano, et al.
Cancers|May 21, 2020
Harnessing Gene Expression Profiles for the Identification of Ex Vivo Drug Response Genes in Pediatric Acute Myeloid LeukemiaDavid G J Cucchi, Costa Bachas, Marry M van den Heuvel-Eibrink, et al.
Plos One|April 8, 2015
Gene expression profiles associated with pediatric relapsed AMLCosta Bachas, Gerrit Jan Schuurhuis, C Michel Zwaan, et al.
British Journal of Haematology|June 26, 2014
Clinical relevance of molecular aberrations in paediatric acute myeloid leukaemia at first relapseCosta Bachas, Gerrit Jan Schuurhuis, Dirk Reinhardt, et al.
Leukemia|January 25, 2024
Impact of hemodilution on flow cytometry based measurable residual disease assessment in acute myeloid leukemiaJesse M Tettero, Maaike E Heidinga, Tim R Mocking, et al.
Immunotherapy|November 6, 2013
Procedures for the expansion of CD14(+) precursors from acute myeloid leukemic cells to facilitate dendritic cell-based immunotherapyWillemijn van den Ancker, Pepijn G J B Wijnands, Jurjen M Ruben, et al.
Cytometry. Part B, Clinical Cytometry|September 28, 2023
Analytical assay validation for acute myeloid leukemia measurable residual disease assessment by multiparametric flow cytometryJesse M Tettero, Naveen Dakappagari, Maaike E Heidinga, et al.
Blood|July 2, 2010
High-frequency type I/II mutational shifts between diagnosis and relapse are associated with outcome in pediatric AML: implications for personalized medicineCosta Bachas, Gerrit Jan Schuurhuis, Iris H I M Hollink, et al.
Pageof 44

Showing results (141-150 of 433) with videos related to

Sort By:
Pageof 44
Oncogenesis|June 19, 2019
Targeting the cell cycle in head and neck cancer by Chk1 inhibition: a novel concept of bimodal cell deathAnne M van Harten, Marijke Buijze, Richard van der Mast, et al.
BMC Bioinformatics|August 22, 2018
Rscreenorm: normalization of CRISPR and siRNA screen data for more reproducible hit selectionCosta Bachas, Jasmina Hodzic, Johannes C van der Mijn, et al.
Ecotoxicology and Environmental Safety|May 7, 2024
Characterization of fire investigators' polyaromatic hydrocarbon exposures using silicone wristbandsUmer Bakali, Jeramy L R Baum, Paola Louzado-Feliciano, et al.
Cancers|May 21, 2020
Harnessing Gene Expression Profiles for the Identification of Ex Vivo Drug Response Genes in Pediatric Acute Myeloid LeukemiaDavid G J Cucchi, Costa Bachas, Marry M van den Heuvel-Eibrink, et al.
Plos One|April 8, 2015
Gene expression profiles associated with pediatric relapsed AMLCosta Bachas, Gerrit Jan Schuurhuis, C Michel Zwaan, et al.
British Journal of Haematology|June 26, 2014
Clinical relevance of molecular aberrations in paediatric acute myeloid leukaemia at first relapseCosta Bachas, Gerrit Jan Schuurhuis, Dirk Reinhardt, et al.
Leukemia|January 25, 2024
Impact of hemodilution on flow cytometry based measurable residual disease assessment in acute myeloid leukemiaJesse M Tettero, Maaike E Heidinga, Tim R Mocking, et al.
Immunotherapy|November 6, 2013
Procedures for the expansion of CD14(+) precursors from acute myeloid leukemic cells to facilitate dendritic cell-based immunotherapyWillemijn van den Ancker, Pepijn G J B Wijnands, Jurjen M Ruben, et al.
Cytometry. Part B, Clinical Cytometry|September 28, 2023
Analytical assay validation for acute myeloid leukemia measurable residual disease assessment by multiparametric flow cytometryJesse M Tettero, Naveen Dakappagari, Maaike E Heidinga, et al.
Blood|July 2, 2010
High-frequency type I/II mutational shifts between diagnosis and relapse are associated with outcome in pediatric AML: implications for personalized medicineCosta Bachas, Gerrit Jan Schuurhuis, Iris H I M Hollink, et al.
Pageof 44